Impact BioMedical Inc. (IBO) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Impact BioMedical Inc. (IBO) closed at USD 3.40 on 2026-10-14, a change of -53.3 % over the past year, with a market capitalization of USD 26.98M.

Impact BioMedical Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Impact BioMedical Inc. key figures

Previous close

USD 3.40 (2026-10-14)

1-year change

-53.3 %

Market cap

USD 26.98M

Enterprise value

USD 30.22M

P/E ratio (trailing)

0.33

P/E ratio (forward)

n/a

EPS (trailing)

9.50

EPS (forward)

n/a

PEG ratio

n/a

Price to book

2.51

Revenue growth

-57.1 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

1.13

Employees

2

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Impact BioMedical Inc.

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use as health supplements and medications. Further, it is developing 3F (functional fragrance formulation), a formulation of botanical ingredients. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. Impact BioMedical Inc. operates as a subsidiary of DSS BioHealth Security, Inc

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Impact BioMedical Inc. and compare it with other stocks.